EN
HI
Summary
As of 26 Aug, 2026, Morepen Laboratories stock price is ₹95.44. During the trading session, the stock has moved between an intraday low of ₹94.06 and an intraday high of ₹96.37. Over the last 52 weeks, Morepen Laboratories has traded between ₹33.05 and ₹98.28.
The stock has recorded a trading volume of 37,97,131 shares, with a market capitalization of ₹547953699. Its Average Traded Price (ATP) is ₹95.30, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 80 @ ₹95.44.
Morepen Laboratories has an upper circuit limit of ₹103.29 and a lower circuit limit of ₹84.51. The total value traded stands at ₹36.19 CR, and the delivery percentage for the day is 29.88%.
The stock is currently traded with a market lot size of 1. Morepen Laboratories also offers a dividend yield of 0.21%.
Morepen Laboratories share price chart
Morepen Laboratories Share Key Metrics
Volume
37.97 L
Market Cap
5145.29 CR
LTQ@LTP
80@95.44
ATP
95.3
Var Margin
100 %
Circuit Range
84.51-103.29
Delivery %
29.88 %
Value
36.19 CR
ASM/GSM
No
Market Lot
1
Morepen Laboratories Fundamentals
P/E Ratio
36.61
P/B Ratio
3.95
Div. Yield
0.21
Sector P/E
69.27
Sector P/B
3.36
Sec. Div. Yield
0.51
Morepen Laboratories Resistance and Support
Pivot 94.06
Resistance
First Resistance
95.42
Second Resistance
96.93
Third Resistance
98.29
Support
First Support
92.55
Second Support
91.19
Third Support
89.68
Morepen Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 94.36 | 95.44 | 1.64% | 96.37 | 94.06 |
| Tue Aug 25 2026 | 94.91 | 93.9 | -1.39% | 95.56 | 92.69 |
| Mon Aug 24 2026 | 96 | 95.22 | -0.82% | 98.27 | 94 |
Morepen Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-05-22 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Morepen Laboratories News
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Acquisition
Morepen Laboratories has invested Rs. 20 crore in its wholly-owned subsidiary, Morepen RX Limited, by acquiring 2 crore equity shares at Rs. 10 each. This capital infusion is intended to strengthen Morepen RX's capital base and support its business operations.
Aug 06 2026 17:10:14
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Morepen Laboratories' Q1 FY27 monitoring report discloses a Rs.117.94 crore GST show cause notice for alleged erroneous refunds (FY21-24). The company has obtained an interim stay, but the matter remains sub judice with potential financial implications.
Aug 04 2026 15:46:12
Read More
Morepen Laboratories Management
| Name | Position |
|---|---|
| Sushil Suri | Chairman & Managing Director |
| Sanjay Suri | Whole Time Director |
Morepen Laboratories Similar Stocks
Kovai Medical Center & Hospital Ltd.
5963.50
-22.00 (0.37%)
Orchid Pharma Ltd.
1040.50
1.95 (0.19%)
Innova Captab Ltd.
1040.45
0.05 (0.00%)
Bliss GVS Pharma Ltd.
563.00
1.50 (0.27%)
FDC Ltd.
346.75
3.10 (0.90%)
Artemis Medicare Services Ltd.
326.35
2.65 (0.82%)
Supriya Lifescience Ltd.
784.65
-7.00 (0.88%)
IOL Chemicals And Pharmaceuticals Ltd.
182.82
10.45 (6.06%)
RPG Life Sciences Ltd.
2585.00
0.50 (0.02%)
Gufic Biosciences Ltd.
417.70
4.05 (0.98%)
Morepen Laboratories FAQs
The Buying Price of Morepen Laboratories share is 95.44 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Morepen Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Morepen Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Morepen Laboratories shares is 36.61. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Morepen Laboratories shares is 3.95. Useful to assess the stock's value relative to its book value.
To assess Morepen Laboratories’s valuation compare Sector P/E, P/B which are 69.27 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Morepen Laboratories is 5145.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Morepen Laboratories share price is 98.28 & 33.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Morepen Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MOREPENLAB
Or Download Choice FinX App
Invest in MOREPENLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade